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SUMMARY. Introduction. Gestational diabetes is a very important obstetrical issue and one of the most frequent meta-
bolic disorders with differing prevalence among various populations. Aim. To determine the prevalence of gestational 
diabetes in Croatia and to detect main risk factors and adverse pregnancy outcomes associated with gestational diabetes. 
Methods. This is a cross sectional study performed using data from medical birth certifi cates collected in 2014 in Croatia. 
All pregnant women who gave birth in year 2014 were included in the study, excluding those with known diabetes mel-
litus type I or type II. Results. Among 39.132 deliveries in 2014 incidence of gestational diabetes was 4.67%. Women 
with gestational diabetes were older, more overweight before pregnancy but gained less weight during pregnancy (all P’s 
< 0.001). Onset of labour among women with gestational diabetes was less often spontaneous and more often induced. 
Also, women with gestational diabetes had a signifi cantly lower incidence of vaginal delivery and concomitantly a 
higher incidence of delivery by caesarean section. Women with gestational diabetes gave birth to infants with higher 
birth weight, but other neonatal complications were not more often present among neonates of women with gestational 
diabetes compared to neonates of women without gestational diabetes. Conclusion. Prevalence of gestational diabetes in 
Croatia based on medical birth certifi cates is 4.67% and gestational diabetes in Croatia is associated with important risk 
factors and adverse perinatal outcomes.
Introduction
Gestational diabetes (GD) is a very important obstet-
rical issue and one of the most frequent metabolic disor-
ders affecting up to one in seven births (14.2%) world-
wide.1 It is defi ned as carbohydrate intolerance of vari-
able severity with onset or fi rst recognition during preg-
nancy that is not clearly overt diabetes.2 Specifi cally, 
according to recent guidelines by World Health Organ-
isation, GD is diagnosed if one or more of the following 
criteria are met: fasting plasma glucose 5.1–6.9 mmol/l, 
1-hour plasma glucose ≥ 10.0 mmol/l or 2-hour plasma 
glucose 8.5–11.0 mmol/l following a 75g oral glucose 
load, while higher values of hyperglycaemia are consid-
ered diagnostic for overt diabetes in pregnancy.3
Prevalence of GD differs among various populations 
according to ethnicity, race, age, screening polices and 
diagnostic criteria used,1,4 and is refl ective of prevalence 
of type 2 diabetes in that population. Therefore, an indi-
vidual from a population with high prevalence of type 2 
diabetes is at higher risk of developing GD.5 It is diffi -
cult to compare GD prevalence rates across popula-
tions, mainly because of different screening policies 
and diagnostic criteria used in different countries, as 
well as particular occurrence of various risk factors as-
sociated with GD. An additional cause of wide varia-
tions in estimated GD prevalence among populations is 
the diversity of criteria used for its screening and diag-
nosis. Prevalence of gestational diabetes is reported to 
be as high as 9.2% in the USA6 compared to Europe 
where it is lower and most often reported in 2–6% of 
pregnancies.7 In Croatia, awareness regarding GD has 
been continuously rising over recent years, however re-
porting and accurate epidemiological data on gestation-
al diabetes prevalence and complications are still scarce.
A lot of factors seem to contribute to the development 
of gestational diabetes among which maternal age, obe-
sity and excessive weight gain during pregnancy are the 
most important.8–10 Changes in incidence of these fac-
tors in recent years lead to an increasing number of 
pregnant women being burdened by GD in their preg-
nancy.11–13 Also, high parity, history of diabetes mellitus 
in fi rst degree relatives, short stature, polycystic ovary 
syndrome (PCOS), past history of GD or poor pregnan-
cy outcomes, pre-eclampsia, and multifetal pregnancy 
are known risk factors for development of GD, even 
though their exact impact on raising the risk for devel-
oping GD is not known.14–16 Adverse perinatal outcomes 
associated with GD reported in literature are excessive 
fetal growth leading to macrosomia, infants large for 
gestational age and consequently obstructed labour, in-
creased rate of caesarean deliveries17 shoulder dystocia 
and other birth injuries.9 GD is also related to the risk of 
neonatal hypoglycaemia, hyperbilirubinemia, hypocal-
caemia, polycythaemia and respiratory distress.15
The aim of this study was to determine the prevalence 
of GD in Croatia and to detect main risk factors and 
adverse pregnancy outcomes associated with GD in our 
population.
Materials and methods
This cross sectional study was performed using data 
from medical birth certifi cates (MBC) collected in Cro-
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atia as a part of perinatal statistics data reported to the 
Croatian Institute of Public Health (CIPH). It is manda-
tory to complete the medical birth certifi cate by the doc-
tor attending each birth for mother and her new-born 
child. The doctor derives data from medical charts, 
which are assigned to each mother during her hospital 
stay where everything that occurs during her stay is 
noted. Completed medical birth certifi cates are then 
regularly sent to and collected at CIPH.
Data from medical birth certifi cates used in this study 
consists of maternal data (age, height, weight before 
and at the end of pregnancy), antenatal and obstetric is-
sues (presence of GD, onset of delivery, mode of deliv-
ery, adverse delivery outcomes) as well as perinatal out-
comes and neonatal data (birth weight, fi ve minute Ap-
gar score, early neonatal complications and congenital 
malformations).
All pregnant women who gave birth in year 2014 
were included, excluding those with known diabetes 
mellitus type I or type II.
Present national guidelines for diagnosis of GD by 
the Croatian Society for Gynaecology and Obstetrics 
are based on the fi ndings of the HAPO study and the 
International Association of Diabetes and Pregnancy 
Study Group (IADPSG)18 and recommend performing a 
one step 75-g OGTT test at 24–28 weeks of pregnancy 
in women not previously diagnosed with overt diabetes. 
GD is diagnosed if plasma glucose values meet or ex-
ceed: fasting value 5.1mmol/L, 1-hour value 10.0 
mmol/L and 2-hours value 8.5 mmol/L.19
All statistical analyses were performed using STA-
TISTICA ver. 12.0. Normality of distribution was tested 
using Shapiro-Wilks test, while homogeneity of vari-
ance was tested using Levene’s test. Differences be-
tween groups of independent continuous variables were 
analysed using student t-test for two independent sam-
ples (groups) while differences in the occurrence of in-
dividual conditions (categorical variables) were com-
pared using the chi2 test. Statistical signifi cance was 
defi ned as P<0.05.
Results
A total of 39.132 deliveries with 39.788 born children 
between 1st of January 2014 and 31st of December 2014 
had been reported through medical birth certifi cates to 
CIPH and analysed in this study. Among all women 
who gave birth, 1.869 had GD as per predefi ned crite-
ria,19 revealing an incidence of GD of 4.67%. Women 
with GD were older and more overweight before preg-
nancy, but gained less weight during pregnancy com-
pared to the rest of the Croatian pregnant population in 
the studied period. All of these fi ndings were statisti-
cally signifi cant (p < 0.001, student t test) and are pre-
sented in table 1.
Some differences in labour characteristics and com-
plications as well as early neonatal complications be-
tween women with and without GD are presented in 
table 2. In occasional cases some data were missing in 
medical birth certifi cates resulting in different numbers 
listed in tables compared to the total number of partici-
pants included in the study.
Table 2. Characteristics and outcomes of pregnancies with and without GD
Pregnancy outcome Without GD*n (%)
With GD*
n (%) p values
Newborn weight 37770 (100) 1869 (100)
p<0.001
BW<2500g 2013 (5.33) 96 (5.14)
BW 2500–4000g 31534 (83.49) 1459 (78.06)
BW>4000g 4223 (11.18) 314 (16.80)
Newborn 5 min 
Apgar score 34629 (100) 1729 (100)
p=0.085Apgar score <3 168 (0.49) 15 (0.87)
Apgar score 4-5-6 183 (0.53) 8 (0.46)
Apgar score ≥7 34278 (98.99) 1706 (98.67)
Onset of labour 37737 (100) 1868 (100)
p<0.001
Spontaneous onset 30368 (80.47) 1256 (67.24)
Induction of labour 4165 (11.04) 354 (18.95)
Elective C.S. 3204 (8.49) 258 (13.81)
Labour complications
PROM 838 (2.22) 52 (2.78) p=0.109
Genital lacerations 4324 (11.45) 283 (15.14) p<0.001
Retained placenta 692 (1.83) 30 (1.61) p=0.472
Postpartum hemorrhage 62 (0.16) 2 (0.11) p=0.759
Shoulder dystocia 72 (0.19) 2 (0.11) p=0.587
Episiotomy 25531 (30.64) 11276 (30.71) p=0.950
Mode of delivery 37655 (100) 1865 (100)
p<0.001
Vaginal delivery 29657 (78.76) 1271 (68.15)
Operative vaginal 
delivery 455 (1.21) 19 (1.02)
Caesarean section 7543 (20.03) 575 (30.83)
Neonatal complications
RDS 237 (0.63) 12 (0.64) p=0.938
Other respiratory 
complications 437 (1.16) 13 (0.70) p=0.661
Hyperbilirubinemia 5565 (14.73) 304 (16.27) p=0.069
Sepsis 196 (0.52) 11 (0.59) p=0.684
Intracranial 
hemorrhage 316 (0.84) 11 (0.59) p=0.247
Birth trauma 472 (1.25) 45 (2.41) p<0.001
Congenital 
malformations 930 (2.46) 59 (3.16) p=0.060
* BW – birth weight, GD – Gestational diabetes, PROM – Premature 
rupture of membranes
Table 1. Maternal and new-born characteristics of women with GD in 
Croatia in 2014
Without GD* With GD*
p value
Mean ± SD Mean ± SD
Maternal characteristic n=37263 n=1829
Age (years) 29.49 ± 5.33 31.34 ± 5.19 <0.001
BMI (kg/m2) 23.37 ± 4.11 26.03 ± 5.64 <0.001
Weight gain (kg) 14.17 ± 5.71 12.49 ± 5.81 <0.001
Newborn characteristic n=37770 n=1869
Infant birth weight (g) 3386 ± 564.42 3458 ± 613.52 <0.001
* GD: gestational diabetes
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Statistically signifi cant difference between women 
with and without GD was present in pregnancy out-
comes (all p’s <0.001). Onset of labour among women 
with GD was less often spontaneous and more often in-
duced. Also, women with GD had a signifi cantly lower 
incidence of vaginal delivery and concomitantly a high-
er incidence of delivery by caesarean section, while 
rates of operative vaginal deliveries and episiotomy 
were similar. Concerning labour complications, no dif-
ference was found between women with or without GD 
in prevalence of premature rupture of membranes, re-
tained placenta, postpartum haemorrhage, and shoulder 
dystocia while statistically signifi cant difference was 
found concerning prevalence of vaginal and perineal 
lacerations.
Women with GD gave birth to infants with higher 
birth weight and more often to infants who weighed 
above 4000g. Apgar scores after 5 minutes of infants of 
women with GD were more often critically low (0,1,2 
or 3) but the difference was not statistically signifi cant. 
Neonatal complications including RDS, other respira-
tory complications, hyperbilirubinemia, sepsis, intra-
cranial haemorrhage and congenital malformations 
were not more often present among neonates of women 
with GD (all P’s >0.05) compared to neonates of wom-
en without GD. The only exception was neonatal birth 
trauma, which was more often present among women 
with GD compared to those without. Birth trauma refers 
to intracranial haemorrhage and injuries to central or 
peripheral nervous system, scalp or skeleton.
Discussion
According to medical birth certifi cates, prevalence of 
GD in Croatia is 4.67% which is consistent with GD 
prevalence in other European countries reported by 
Buckley et al.7 Still, since Croatian national guidelines 
recommend usage of IADPSG criteria for diagnosis of 
GD with a lower threshold for diagnosis of GD and 
since recent studies suggest IADPSG criteria result in a 
diagnosis of GD in about 18% of pregnancies,20,21 a con-
siderably higher GD prevalence would be presumed. 
This discrepancy can be interpreted in two ways. Pri-
marily, it can be presumed that a mixture of two diag-
nostic criteria was used in different Clinics and by dif-
ferent medical doctors during the study period- the cur-
rent one and the former criteria from 1999 which in-
clude a higher glucose thresholds.22 Secondly, it can be 
hypothesised that GD was not accurately reported in 
medical birth certifi cates and consequently underesti-
mated among women in Croatia. This is also one of the 
possible limitations of this study. Either way, GD preva-
lence of 4.67% is a valuable starting point for managing 
GD in Croatia. It is essential to have accurate national 
data on GD prevalence since differences in diagnostic 
criteria and population specifi city make it diffi cult to 
compare frequencies of GD among various popula-
tions.23 Also, epidemiological data on GD are the main 
prerequisite for prevention, diagnosis and management 
of this metabolic disorder.
Concerning associated risk factors for GD, the Croa-
tian population does not differ signifi cantly compared 
to neighbouring European countries since it has been 
shown that age and obesity prior to pregnancy play a 
key role in development of GD.8–10 Therefore, older and 
more obese women planning to conceive or those al-
ready pregnant should be additionally counselled and 
educated before pregnancy and early in pregnancy in 
order to prevent development of GD. A systematic re-
view and meta-analysis by Oteng-Ntim el al. confi rms 
lifestyle interventions for overweight and obese preg-
nant women are associated with a trend towards a re-
duced prevalence of gestational diabetes.24 The fact that 
women burdened with GD in this study group gained 
less weight during pregnancy can be interpreted as good 
perinatal management as appropriate diet, weight con-
trol and regular exercise are the fi rst steps in manage-
ment of GD.
Concerning pregnancy outcome, higher birth weights 
of infants, especially above 4000g, are expected since 
in GD maternal hyperglycaemia results in more blood 
glucose transferred through the placenta into fetal circu-
lation. Consequently, more glucose in the fetus is stored 
as body fat causing macrosomia and excessive fetal in-
sulin levels generate accelerated fetal growth.25 Higher 
rates of fetal macrosomia among women burdened with 
GD is in concordance with previously published stud-
ies.25,26
Higher rates of induction of labour among women 
with GD are expected as clinical guidelines recommend 
that pregnant women with GD and with estimated fetal 
weight between 3800 and 4000g or poor glycaemic 
control should be induced between 38 and 39 weeks, 
while those with infants estimated above 4000g are of-
fered elective caesarean section.15 Still, this is only a 
presumption since no national guidelines on manage-
ment of GD exist in Croatia. Higher rates of caesarean 
section can be interpreted by a mixture of these two out-
comes, since estimated fetal weight above 4000g among 
women with GD and unsuccessful labour induction lead 
performing a caesarean section. A potential limitation 
of this study is the fact that validation of the acquired 
data at CIPH is not performed, nor has the accuracy of 
the medical births certifi cates been assessed. However, 
as an educated medical professional (doctor) completes 
the medical birth certifi cate we have full reason to as-
sume that the data are representative and correct, with 
possible errors potentially occurring.
Conclusion
Prevalence of GD in Croatia based on MBC is 4.67%. 
We believe this result still does not represent the com-
plete picture of GD prevalence in Croatia due to under-
reporting and/or underdiagnosis. Medical birth certifi -
cates are a useful tool in estimating GD prevalence 
among women in Croatia but further research is needed 
to determine if and to what extent medical birth certifi -
cates are underestimating GD prevalence in Croatia due 
to low reporting.
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GD is a signifi cant public health concern because of 
its long-term implications for maternal and child health, 
primarily increased risk of developing diabetes mellitus 
later in life. This study provides fundamental informa-
tion about prevalence of GD in Croatia, population 
based risk factors and adverse pregnancy outcome, 
which is the fi rst step for appropriate screening, man-
agement and treatment of this condition. Further re-
search for proceeding years is needed to evaluate the 
trend of GD prevalence, which is key for improvement 
of perinatal care related to gestational diabetes among 
Croatia population.
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SAŽETAK. Gestacijski dijabetes važan je izazov u suvremenom porodništvu i najčešći metabolički poremećaj u trudnoći 
koji zahvaća jednu od sedam trudnoća diljem svijeta. Prevalencija ove bolesti se značajno razlikuje između promatranih 
populacija jer ovisi o brojnim čimbenicima poput dobi i prehrambenih navika trudnica, rase te vrsti metoda probira i 
dijagnostičkih kriterija koji se koriste za dijagnozu same bolesti. Prema suvremenim smjernicama Svjetske zdravstvene 
organizacije i Hrvatskog društva za ginekologiju i porodništvo dijagnoza gestacijskog dijabetesa postavlja se ako 
vrijednost glukoze u krvi bilo kad u trudnoći iznosi: natašte 5,1–6,9 mmol/L ili kod testa opterećenja 75g glukozom 
(OGTT test): natašte 5,1–6,9 mmol/L, nakon 1 sat ≥10.0 mmol/L ili nakon 2 sata 8,5–11,0 mmol/L.
Cilj. Ovim istraživanjem željeli smo utvrditi učestalost gestacijskog dijabetesa u Hrvatskoj, glavne rizične čimbenike i 
ishode trudnoća povezanih s gestacijskim dijabetesom u Hrvatskoj.
Metode. Provedeno je presječno istraživanje pomoću podataka iz prijava porođaja sakupljenih u 2014. godini u 
 Hrvatskoj. Prijava porođaja je propisano zdravstveno-statističko istraživanje kojeg ispunjava zdravstveno osoblje pri 
porođaju svakog djeteta, provodi ga Hrvatski zavod za javno zdravstvo te služi za nadzor i praćenje perinatalne skrbi i 
perinatalnog zdravlja u Republici Hrvatskoj. U istraživanje su bile uključene sve trudnice koje su rodile u 2014. godini 
u Hrvatskoj, isključivši one koje boluju od šećerne bolesti tipa 1 ili 2. Za statističku analizu korišten je program Statisti-
ca ver. 12.0 te je statistički značajnom smatrana vrijednost empirijske razine značajnosti p<0,05.
Rezultati. Od 39132 žene koje su rodile u 2014. godini 1869 je imalo gestacijski dijabetes, što čini prevalenciju gesta-
cijskog dijabetesa 4,67%. Žene s gestacijskim dijabetesom bile su starije naspram žena koje nisu imale gestacijski dija-
betes, bile su češće pretile prije trudnoće, ali su dobile manje kilograma tijekom trudnoće (svi p < 0,001). Početak 
porođaja kod žena s gestacijskim dijabetesom bio je rjeđe spontani i češće induciran. Također, žene s gestacijskim dija-
betesom imale su značajno manju incidenciju dovršetka porođaja vaginalnim putem i popratno veću incidenciju 
dovršetka porođaja carskim rezom naspram žena koje nisu imale gestacijski dijabetes (svi p <0,001). Žene s gestacijskim 
dijabetesom rađale su djecu veće tjelesne težine, dok druge neonatalne komplikacije nisu bile učestalije kod novorođenčadi 
žena s gestacijskim dijabetesom u usporedbi s novorođenčadi žena koje nisu imale gestacijski dijabetes.
Zaključak. Prevalencija gestacijskog dijabetesa u Hrvatskoj temeljem prijava poroda je 4,67% te je gestacijski dijabetes 
u trudnoći povezan s važnim rizičnim čimbenicima i nepoželjnim perinatalnim ishodima. Smatramo da su ovi podatci 
temelj i prvi korak za primjereni probir, praćenje i liječenje trudnoća kompliciranih gestacijskim dijabetesom. Zbog 
kratkoročnih i dugoročnih posljedica koje ovo stanje ima na zdravlje djeteta i majke (prvenstveno povećan rizik razvoj 
dijabetesa kasnije tijekom života), važno je osvjestiti javnozdravstveni značaj gestacijskog dijabetesa te u rješavanje i 
razgovor oko ovog problema uključiti širu medicinsku javnost.
